Author:
Alimohammadi Mina,Rahimzadeh Payman,Khorrami Ramin,Bonyadi Mojtaba,Daneshi Salman,Nabavi Noushin,Raesi Rasoul,Farani Marzieh Ramezani,Dehkhoda Farshid,Taheriazam Afshin,Hashemi Mehrdad
Reference303 articles.
1. CAR T-cell therapy in multiple myeloma: more room for improvement;Teoh;Blood Cancer J.,2021
2. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway;Zhang;Oncogene,2003
3. Elsevier;Kazandjian;Semin. Oncol.,2016
4. Multiple myeloma: focus on international epidemiology literature;Veres;Acta Med. Transilv.,2022
5. Value and cost of myeloma therapy;Rajkumar;Am. Soc. Clin. Oncol. Educ. Book,2018